Compare KRRO & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRRO | EHTH |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 104.0M |
| IPO Year | 2019 | 2006 |
| Metric | KRRO | EHTH |
|---|---|---|
| Price | $13.67 | $1.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | ★ $34.80 | $3.33 |
| AVG Volume (30 Days) | 197.4K | ★ 584.0K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.43 |
| EPS | N/A | ★ N/A |
| Revenue | $6,392,000.00 | ★ $251,395,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 181.46 | 45.86 |
| 52 Week Low | $5.20 | $1.20 |
| 52 Week High | $55.89 | $7.09 |
| Indicator | KRRO | EHTH |
|---|---|---|
| Relative Strength Index (RSI) | 59.66 | 53.16 |
| Support Level | $12.17 | $1.21 |
| Resistance Level | $15.11 | $1.58 |
| Average True Range (ATR) | 1.07 | 0.10 |
| MACD | 0.17 | 0.05 |
| Stochastic Oscillator | 67.20 | 87.50 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.